Browsing Caprisa (Centre for the Aids programme of research in South Africa) by Advisor "Taylor, Douglas."
Now showing items 1-4 of 4
An adaptive design to bridge the gap between phase 2b/3 microbicide effectiveness trials and evidence required for licensure. (Sage., 2012)Background. Vaginally and rectally applied microbicides are being developed to help prevent sexual acquisition of HIV. Due to the lack of surrogate outcomes, the path toward licensure typically moves directly from expanded ...
Assessing adherence in the CAPRISA 004 tenofovir gel HIV prevention trial: results of a nested case–control study. (Springer., 2014)Abstract available in pdf.
(American Association for the Advancement of Science., 2008)No abstract available.
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. (American Association for the Advancement of Science., 2010)The Centre for the AIDS Program of Research in South Africa (CAPRISA) 004 trial assessed the effectiveness and safety of a 1% vaginal gel formulation of tenofovir, a nucleotide reverse transcriptase inhibitor, for the ...